Story excerpt provided by Crain’s Cleveland Business.
Written by Timothy Magaw.
When University Hospitals announced its $250 million drug development initiative — The Harrington Project for Discovery & Development — three years ago last month, its leaders, admittedly, had a difficult time describing exactly how it was going to solve the problems that kill so many promising drugs in their infancies.
Click here to read the complete article.
Originally published March 8, 2015.